Synthetic method of 3-(3-pyridyl)-5-ethyl formate-pyrazole

A technology of ethyl formate and monoethyl oxalate, applied in the fields of medicine and chemical industry, can solve the problems of requiring low temperature, long reaction time, complicated post-processing, etc., and achieve the effects of avoiding harsh conditions, shortening the production process, and high product purity

CN104119313AInactive Publication Date: 2014-10-29苏州科捷生物医药有限公司
1 Cites 1 Cited by

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
Publication Date
2014-10-29
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention discloses a novel synthetic method of 3-(3-pyridyl)-5-ethyl formate-pyrazole. Easily available raw material 3-acetyl pyridine and sodium alkoxide as alkali react with diethyl oxalate to obtain a key intermediate sodium salt, which then reacts with hydrazine hydrate at 50 DEG C to prepare the 3-(3-pyridyl)-5-ethyl formate-pyrazole. The method has the advanategs of mild and simple reaction conditions, low cost, high yield and simple operation, and is suitable for industrial production.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to a synthesis process of 3-(3-pyridine)-5-ethyl carboxylate-pyrazole, which belongs to the technical fields of medicine and chemical industry. Background technique

[0002] Pyridine derivatives are important pharmaceutical intermediates with a wide range of uses.

[0003] 3-(3-pyridine)-5-ethyl carboxylate-pyrazole is a pyridine derivative, which can be used to synthesize antithrombotic drugs (BMCL2004, 14, 5263-5268); it can also synthesize antibacterial drugs (BMCL2000, 10, 1211 -1214).

[0004] The synthetic methods reported in the literature are as follows:

[0005] Route A (TL2010, 51, 5915-5918)

[0006]

[0007] Route B (US6506747)

[0008]

[0009] In Route A, the dangerous, explosive ethyl diazoacetate is required.

[0010] In route B, the first step needs to use a strong base LiHMDS at a low temperature of -78°C; the last step is to react with hydrazine hydrate overnight at 90°C.

[0011] Comparing the above...

Examples

Embodiment 1

[0021] Embodiment 1: synthetic compound 2

[0022] Sodium ethoxide (44g, 0.65 mol) was dissolved in absolute ethanol (500mL), under ice water cooling, slowly added dropwise a mixture of 3-acetylpyridine (79g, 0.65 mol) and diethyl oxalate (95g, 0.65 mol) solution, after addition, heated to 60°C and stirred for 5 hours, cooled, filtered with suction, washed with petroleum ether, and dried to obtain 145 g of light yellow solid compound (2), yield: 91.8%.

Embodiment 2

[0023] Example 2: Synthesis of 3-(3-pyridine)-5-ethyl formate-pyrazole (compound 3)

[0024] Compound (2) (64g, 0.26 mol) was added to glacial acetic acid (100mL) at room temperature, and then 85% hydrazine hydrate (15g, 0.26 mol) was added dropwise using a constant pressure dropping funnel, and stirred at 60°C for 4 hours after the addition was complete , cooled, neutralized to pH 7-8 with saturated sodium carbonate solution, extracted with ethyl acetate (300mL), washed with saturated brine, anhydrous Na 2 SO 4 Dry and concentrate to obtain 48 g of off-white solid 3-(3-pyridine)-5-ethyl carboxylate-pyrazole, yield: 85.1%.

[0025] HNMR (DMSO-d6, 300MHz): δ9.07(1H, s), 8.62(1H, d), 8.14(1H, d), 7.38(1H, m), 7.19(1H, s), 4.43(2H, q), 1.42 (3H, t).